Jabil Inc. is consolidating its healthcare businesses under Jabil Healthcare. These include Jabil’s embedded-sensors business, its injection molding business through Nypro, and its orthopedics, spine, trauma, and medical instruments operations acquired from Johnson & Johnson. The company’s strategy “allows us to be unified in our approach to our customers, to understand their needs and roadmap, and to understand how to offer them value,” Steve Borges, CEO and EVP of Jabil Healthcare (pictured above), told MD+DI.
One of those needs includes keeping up with today’s trends of home healthcare and the digitalization of data, Borges said. “Patients are taking more control of their health, and they need products that provide feedback to patients, caregivers, and doctors on the efficacy of procedures,” he said. “They need smart devices.”
In addition, today’s value-based-care programs require a better understanding of the efficacy of procedures, he added. “This requires some level of technology in products.”
There’s also a need to “collect a lot of data to understand a disease state and treatment, and it has to be good data,” Borges added. “The challenge is there hasn’t been a catalyst to share data—but it will happen over time.”
Jabil has been providing electronics, circuit board assemblies, and sensor technologies to medical device companies for years, and customers have been utilizing Nypro’s injection molding business, he says. All the businesses are now unified under one umbrella, but “customer access won’t change, and there is no structural change in leadership,” said Borges. “It will be seamless—no reorganization to confuse customers—it will just ensure they get the very best of Jabil to support their needs.”
For instance, Jabil’s capabilities in multiple sectors could benefit medical device companies. “We are seeing sensor technologies from automotive as well as camera technologies from consumer tech cross over into medtech,” he explained. “Now that we are united, we can bring the best to healthcare for better products and better patient outcomes.”
Jabil Healthcare has more than 35 global sites and nearly 20,000 employees. It serves five sectors in the healthcare market: medical devices, orthopedics, diagnostics, pharmaceutical delivery systems, and consumer health.